Takafumi Yukawa

This inventor holds 11 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignees: Takeda Pharmaceutical Company Limited, Cardurion Pharmaceuticals, LLC, Cornell University. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takafumi Yukawa. Retrieved from https://idiyas.com/inventor/takafumi-yukawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 5)

% Patents Active = 81.8

CIPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 11.7

ph-index = 2

Forward Citations = 20(Granted Patents)

Location History:

Kanagawa, JP (2015 - 2023)
Fujisawa, JP (2023)

Company Filing History:

7 out of 1,228

Takeda Pharmaceutical Company Limited

patents

2 out of 11

Cardurion Pharmaceuticals, LLC

Tri-Institutional Therapeutics Discovery Institute

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12767667 - Macrocyclic heterocycle compounds and use thereof (2026-10-20),

2. 12637418 - Heterocyclic compounds as antagonist of NMDA (2026-05-26),

3. 12630509 - Heterocyclic NMDA antagonists (2026-05-19),

4. 12473331 - Macrocyclic compounds as proteasome inhibitors (2025-11-18),

5. 12202832 - Heterocyclic compounds having a calcium-sensing receptor antagonistic activity (2025-01-21),

6. 11834515 - Macrocyclic compounds as proteasome inhibitors (2023-12-05),

7. 11834409 - Heterocyclic NMDA antagonists (2023-12-05),

8. 11197858 - Substituted amines for treating cardiac diseases (2021-12-14),

9. 10919891 - Heterocyclic compound (2021-02-16),

10. 10543212 - Substituted amines for treating cardiac diseases (2020-01-28),

11. 9187453 - Heterocyclic compound (2015-11-17),

Title: Unveiling the Innovations of Inventor Takafumi Yukawa

Introduction:

In the realm of innovative inventions, one name stands out - Takafumi Yukawa. Hailing from Kanagawa, JP, Yukawa is a prolific inventor with a total of 6 patents under his belt, showcasing his groundbreaking contributions to various fields. Let's delve into his latest patents, career highlights, and collaborations that have shaped his journey.

Latest Patents:

Yukawa's latest patents unveil cutting-edge discoveries in the medical domain. He has developed macrocyclic compounds as proteasome inhibitors, paving the way for treatments of a wide array of conditions such as bacterial infections, cancer, and neurodegenerative diseases. Additionally, his work with heterocyclic NMDA antagonists presents innovative solutions for depression, pain management, and other neurological disorders.

Career Highlights:

During his illustrious career, Yukawa has made significant strides in the pharmaceutical industry. He has lent his expertise to renowned companies such as Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals, LLC. Through his innovative research and inventive spirit, Yukawa has left an indelible mark on the field of medicine and beyond.

Collaborations:

Behind every great inventor are talented collaborators who complement their vision. Yukawa has worked closely with esteemed colleagues such as Rei Okamoto and Nobuyuki Matsunaga. Together, they have synergized their efforts to bring forth groundbreaking innovations that have the potential to revolutionize healthcare and pharmaceuticals.

Conclusion:

Inventor Takafumi Yukawa's journey is a testament to the power of innovation and dedication in the realm of patents and inventions. His trailblazing work not only showcases his ingenuity but also underscores the importance of collaboration in driving cutting-edge research forward. Yukawa's legacy serves as an inspiration for aspiring inventors and underscores the transformative impact of inventions on society.

Profile summary based on public USPTO records.